Q3 2025 Holdings
Filed 2025-11-13 | 14 holdings | $491.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $144.4M | 1,534,141 | 29.4% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $109.9M | 5,404,674 | 22.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $104.3M | 8,601,189 | 21.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $46.5M | 700,014 | 9.5% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $34.2M | 5,766,090 | 7.0% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $15.8M | 7,098,133 | 3.2% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $14.3M | 7,857,347 | 2.9% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $5.8M | 1,042,596 | 1.2% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $5.3M | 1,325,848 | 1.1% |
| Passage BIO Inc(PASG) | COM NEW | 702712209 | $5.0M | 623,704 | 1.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $3.8M | 261,687 | 0.8% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $874.1K | 1,055,897 | 0.2% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $677.2K | 546,119 | 0.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $496.6K | 65,954 | 0.1% |